New Research Report on Global Cancer Biomarkers Market 2012-2016 by MarketResearchReports
Summary
The key vendors dominating this market space are Abbott Laboratories, Affymetrix, Inc., Agilent Technologies Inc., Gen-Probe Inc., Hologic, Inc., and Roche Diagnostics Corp.The other vendors mentioned in the report are Agendia BV, Ambrilia Biopharma, Astellas Pharma US Inc., Morphotek, Inc., Gen-Probe, Inc., Veridex LLC, Morphotek, Inc., Immunomedics, Inc., Clarient, Inc. Key questions answered in this report: What will the market size be in 2016 and what will the growth rate be?To Read The Complete Report with TOC Visit: http://www.marketresearchreports.biz/analysis/158768 To Browse All Reports Kindly visit: http://www.marketresearchreports.biz/ For More Information Kindly Contact: Hemendra Parmar State Tower 90 State Street, Suite 700 Albany, NY 12207 United States Tel: +1-518-618-1030 sales@marketResearchReports.biz website:http://www.marketresearchreports.biz/ Blog: http://mrrbiz.blogspot.com/ Albany, NY, January 25, 2013 --( PR.com )-- TechNavios analysts forecast the Global Cancer Biomarkers market to grow at a CAGR of 18.22 percent over the period 2012-2016.One of the key factors contributing to this market growth is the increasing prevalence of cancer.The Global Cancer Biomarkers market has also been witnessing the trend of the emergence of personalized medicines.